Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Benzinga readers can review the latest analyst takes on high-yielding stocks in health care sector. Top analysts & recent news on PRGO, PFE, BMY.
Stocks · News reference
Perrigo Affirms FY2026 Adj EPS Guidance of $2.25-$2.55 vs $2.11 Est; Affirms FY2026 Sales Guidance of $4.019B-$4.189B vs $4.056B Est
Perrigo (NYSE:PRGO) affirms FY2026 Adj EPS guidance from $2.25-$2.55 to $2.25-$2.55 vs $2.11 analyst estimate. Affirms FY2026 sales outlook from $4.019 billion-$4.189 billion to $4.019 billion-$4.189 billion vs $4.056
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Wynn Resorts Posts Upbeat Q2 Earnings, Joins Bloomin' Brands, Shopify, Owens Corning And Other Big Stocks Moving Higher On Wednesday
US stocks rise, Wynn Resorts beat earnings expectations, share price jumps 10.9%. Other companies recording gains in today's session.
Perrigo shares are trading higher after the company reported better-than-expected Q2 financial results and affirmed its FY26 adjusted EPS guidance above estimates.
8-K filing — PERRIGO Co plc (PRGO)
Filed: 2026-08-05 AccNo: 0001585364-26-000143 Size: 788 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits